The Trp64Arg polymorphism of the β 3-adrenergic receptor gene is not associated with obesity or type 2 diabetes mellitus in a large population- based caucasian cohort

Journal of Clinical Endocrinology and Metabolism

Volumn 83, Issue 8, 1998, Pages 2892-2897

  Buettner R ^a   Schaffler A ^a   Arndt, H ^a   Rogler, G ^a   Nusser, J ^a   Zietz, B ^a   Enger, I ^a   Hugl S ^a   Cuk, A ^a   Scholmerich J ^a   Palitzsch, K D ^a,b  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b Klinik und Poliklinik I fur Innere Medizin   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 3 ADRENERGIC RECEPTOR; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ALLELE; ARTICLE; BODY MASS; CAUCASIAN; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATHOGENESIS; PRIORITY JOURNAL; RECEPTOR GENE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ADULT; AGING; ALLELES; ARGININE; BODY MASS INDEX; BODY TEMPERATURE REGULATION; BODY WEIGHT; CHOLESTEROL; COHORT STUDIES; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; ENERGY METABOLISM; FEMALE; GENOTYPE; HUMANS; LIPOLYSIS; MALE; MIDDLE AGED; OBESITY; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RANDOM ALLOCATION; RECEPTORS, ADRENERGIC, BETA; TRYPTOPHAN;

EID: 15444347628     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.83.8.2892     Document Type: Article

References (25)

1. Reaven GM. 1988 Banting lecture. Role of insulin resistance in human disease. Diabetes. 37:1595-1607.
2. Carpene C, Ambid L, Lafontan M. 1994 Predominance of β 3-adrenergic component in catecholamine activation of lipolysis in garden dormouse adipocytes. Am J Physiol. 266:R896-R904.
3. Walston J, Silver K, Bogardus C, et al. 1995 Time of onset of non-insulin dependent diabetes mellitus and genetic variation in the β 3-adrenergic receptor gene. N Engl J Med. 333:343-347.
4. Langin D, Tavernier G, Lafontan M. 1995 Regulation of β 3-adrenoreceptor expression in white fat cells. Fundam Clin Pharmacol. 9:97-106.
5. Arbeeny CM, Meyers DS, Hillyer DE, Bergquist KE. 1995 Metabolic alterations associated with the antidiabetic effect of β 3-adrenergic receptor agonists in obese mice. Am J Physiol. 268:E678-684.
6. Clement K, Vaisse C, Manning BS, et al. 1995 Genetic variation in the β 3-adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity. N Engl J Med. 333:352-354.
7. Widen E, Lehto M, Kanninen T, Walston J, Shuldiner AR, Groop LC. 1995 Association of a polymorphism in the β 3-adrenergic receptor gene with features of the insulin resistance syndrome in Finns. N Engl J Med. 333:348-351.
8. Kadowaki H, Yasuda K, Iwamoto K, et al. 1995 A mutation in the β 3-adrenergic receptor gene is associated with obesity and hyperinsulinemia in Japanese subjects. Biochem Biophys Res Commun. 215:555-560.
9. Urhammer SA, Clausen JO, Hansen T, Pedersen O. 1996 Insulin sensitivity and body weight changes in young white carriers of the codon 64 amino acid polymorphism of the β 3-adrenergic receptor gene. Diabetes. 45:1115-1120.
10. Kurabayashi T, Carey DG, Morrison NA. 1996 The β 3-adrenergic receptor gene Trp64Arg mutation is overrepresented in obese women. Effects on weight, BMI, abdominal fat, blood pressure, and reproductive history in an elderly Australian population. Diabetes. 45:1358-1363.
11. Oksanen L, Mustajoki P, Kaprio J, et al. 1996 Polymorphism of the β 3-adrenergic receptor gene in morbid obesity. Int J Obes Relat Metab Disord. 20:1055-1061.
12. McCance DR, Hanson RL, Charles MA, et al. 1994 Comparison of tests for glycated haemoglobin and fasting and two hour plasma glucose concentrations as diagnostic methods for diabetes. BMJ. 308:1323-1328.
13. Peters AL, Davidson MB, Schriger DL, Hasselblad V. 1996 A clinical approach for the diagnosis of diabetes mellitus. JAMA. 276:1246-1252.
14. Li LS, Lonnqvist F, Luthman H, Arner P. 1996 Phenotypic characterization of the Trp64Arg polymorphism in the β 3-adrenergic receptor gene in normal weight and obese subjects. Diabetologia. 39:857-860.
15. Silver K, Walston J, Wang Y, Dowse G, Zimmet P, Shuldiner AR. 1996 Molecular scanning for mutations in the β 3-adrenergic receptor gene in Nauruans with obesity and noninsulin dependent diabetes mellitus. J Clin Endocrinol Metab. 81:4155-4158.
16. Mauriège P, Bouchard C. 1996 Trp64Arg mutation: of doubtful significance for obesity and insulin resistance. Lancet. 348:698-699.
17. Odawara M, Sasaki K, Yamashita K. 1996 β 3-adrenergic receptor gene variant and Japanese NIDDM: a pitfall in meta analysis. Lancet. 348:896-897.
18. Guan XM, Amend A, Strader CD. 1995 Determination of structural domains for G protein coupling and ligand binding in β 3-adrenergic receptor. Mol Pharmacol. 48:492-498.
19. Candelore MR, Deng L, Tota LM, Kelly LJ, Cascieri MA, Strader CD. 1996 Pharmacological characterization of a recently described human β 3-adrenergic receptor mutant. Endocrinology. 137:2638-2641.
20. Pietri-Rouxel F, St.-John-Manning B, Gros J, Strosberg AD. 1997 The biochemical effect of the naturally occurring Trp64->Arg mutation on human β 3-adrenoreceptor activity. Eur J Biochem. 247:1174-1179.
21. Susulic VS, Frederich RC, Lawitts J, et al. 1995 Targeted disruption of the β 3-adrenergic receptor gene. J Biol Chem. 270:29483-29492.
22. Elbein SC, Hoffman M, Barrett K, et al. 1996 Role of the β 3-adrenergic receptor locus in obesity and noninsulin dependent diabetes among members of Caucasian families with a diabetic sibling pair. J Clin Endocrinol Metab. 81:4422-4427.
23. Thomas RF, Liggett SB. 1993 Lack of β 3-adrenergic receptor mRNA expression in adipose and other metabolic tissues in the adult human. Mol Pharmacol. 43:343-348.
24. Revelli JP, Muzzin P, Paoloni A, Moinat M, Giacobino JP. 1993 Expression of the β 3-adrenergic receptor in human white adipose tissue. J Mol Endocrinol. 10:193-197.
25. Rosenbaum M, Malbon CC, Hirsch J, Leibel RL. 1993 Lack of β 3-adrenergic effect on lipolysis in human subcutaneous adipose tissue. J Clin Endocrinol Metab. 77:352-355.